To main content

Smartfish NutriDrug: Efficient oral drug delivery system for the treatment of cancer and infectious diseases

Smartfish NutriDrug: Efficient oral drug delivery system for the treatment of cancer and infectious diseases

Published 11 March 2016

New solutions for orally administrated drugs are in demand by users, society and the pharmaceutical industry. The overall goal of NutriDrug is to develop a novel and efficient oral drug delivery system for the treatment of cancer and infectious diseases.

Smartfish has several drinks on the market, both for special medical purposes and for athletes for improved immune system and restitution. The drinks are rich in marine oil, natural antioxidants, whey protein, fiber and Vitamin D. An important ingredient and raw material in all Smartfish products are marine DHA and EPA fatty acids from marine oil, a bi-product from Norwegian fish industry. Studies performed for the use of Smartfish drinks for various medical conditions such as inflammation, Alzheimer's disease, COPD, diabetes, cardiovascular diseases and muscle restitution showing positive effects. The results further show that the patented Smartfish formulation results in increased stability and uptake of both marine oil and oil-soluble active compounds from the intestines.

Many potential anti-cancer drugs and antibiotics are difficult to deliver to the disease site. The main goal of the project is to develop a new, efficient oral drug delivery system for the treatment of cancer and infectious diseases.

NutriDrug is an innovation project funded by the NANO2021 program within the Research Council of Norway. The project will be implemented in a close collaboration between Smartfish and SINTEF.

Senior Research Scientist
402 34 744

Project duration

2016 - 2019